Morgan Stanley’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.03M | Buy |
|
|||||
|
2025
Q1 | $3.7M | Buy |
|
|||||
|
2024
Q4 | $2.66M | Buy |
|
|||||
|
2024
Q3 | $553K | Buy |
|
|||||
|
2024
Q2 | $205K | Sell |
|
|||||
|
2024
Q1 | $610K | Sell |
|
|||||
|
2023
Q4 | $2.05M | Buy |
|
|||||
|
2023
Q3 | $11.6M | Buy |
|
|||||
|
2023
Q2 | $17M | Buy |
|
|||||
|
2023
Q1 | $5.47M | Buy |
|
|||||
|
2022
Q4 | $2.21M | Sell |
|
|||||
|
2022
Q3 | $2.64M | Buy |
|
|||||
|
2022
Q2 | $2.25M | Buy |
|
|||||
|
2022
Q1 | $532K | Sell |
|
|||||
|
2021
Q4 | $623K | Buy |
|
|||||
|
2021
Q3 | $585K | Buy |
|
|||||
|
2021
Q2 | $410K | Buy |
|
|||||
|
2021
Q1 | $224K | Sell |
|
|||||
|
2020
Q4 | $118K | Sell |
|
|||||
|
2020
Q3 | $52K | Buy |
|
|||||
|
2020
Q2 | $22K | Buy |
|
|||||
|
2020
Q1 | $3K | Sell |
|
|||||
|
2019
Q4 | $4.76M | Buy |
|
|||||
|
2019
Q3 | $1.87M | Buy |
|
|||||
|
2019
Q2 | $367K | Sell |
|
|||||
|
2019
Q1 | $1.24M | Buy |
|
|||||
|
2018
Q4 | $1.23M | Sell |
|
|||||
|
2018
Q3 | $5.57M | Buy |
|
|||||
|
2018
Q2 | $1.32M | Sell |
|
|||||
|
2018
Q1 | $2.04M | Sell |
|
|||||
|
2017
Q4 | $4.63M | Buy |
|
|||||
|
2017
Q3 | $851K | Buy |
|
|||||
|
2017
Q2 | $541K | Buy |
|
|||||
|
2017
Q1 | $583K | Sell |
|
|||||
|
2016
Q4 | $1.59M | Buy |
|
|||||
|
2016
Q3 | $690K | Buy |
|
|||||
|
2016
Q2 | $2K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $11K | Buy |
|